Wave Life Sciences
79 hedge funds and large institutions have $949M invested in Wave Life Sciences in 2018 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 21 reducing their positions, and 9 closing their positions.
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
52% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 21
22% more capital invested
Capital invested by funds: $780M → $949M (+$169M)
8% more funds holding
Funds holding: 73 → 79 (+6)
4.57% more ownership
Funds ownership: 79.98% → 84.54% (+4.6%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$33.6M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$27.3M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$22M |
| 4 |
BM
Bridger Management
New York
|
+$7.63M |
| 5 |
SIM
Spark Investment Management
New York
|
+$3.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$11.6M |
| 2 |
PA
Perceptive Advisors
New York
|
-$8.41M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$7.09M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.53M |
| 5 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$3.67M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PHK
76
Point72 Hong Kong
Hong Kong
| $12K | +$12.4K | +296 | New |
|
77
Bank of Montreal
Toronto,
Ontario, Canada
| $9K | – | – | – |
|
78
Citigroup
New York
| $2K | -$5.42K | -129 | -68% |
|
|
MAM
79
Meeder Asset Management
Dublin,
Ohio
| $1K | +$1.14K | +27 | +1,350% |
|
|
GPP
80
Great Point Partners
Greenwich,
Connecticut
| – | -$11.6M | -331,085 | Closed |
|
|
CAM
81
Cormorant Asset Management
Boston,
Massachusetts
| – | -$7.09M | -202,079 | Closed |
|
|
IHM
82
Iguana Healthcare Management
New York
| – | -$1.75M | -50,000 | Closed |
|
|
GPCM
83
Granite Point Capital Management
Boston,
Massachusetts
| – | -$1.05M | -30,000 | Closed |
|
84
Two Sigma Investments
New York
| – | -$828K | -23,601 | Closed |
|
|
LSC
85
Lesa Sroufe & Co
Seattle,
Washington
| – | -$226K | -6,440 | Closed |
|
86
Parallax Volatility Advisers
San Francisco,
California
| – | -$63K | -1,806 | Closed |
|
|
TRCT
87
Tower Research Capital (TRC)
New York
| – | -$24K | -698 | Closed |
|
|
CSS
88
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$7K | -200 | Closed |
|
WVE Hedge Fund Activity: Q1 2018 in Review
79 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2018, worth a combined $949M — up 22% from $780M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new WVE positions and 9 closed out — a net gain of 7 holders — while 32 added to existing stakes and 21 trimmed.
The largest buyer was Boxer Capital, adding an estimated $33.6M. The largest seller was Great Point Partners, exiting entirely with an estimated $11.6M sold.
- 79 institutional investors held Wave Life Sciences (WVE) as of Q1 2018, up from 73 in Q4 2017.
- Funds reported $949M of Wave Life Sciences stock for Q1 2018, up 22% quarter-over-quarter.
- 16 funds opened new Wave Life Sciences positions in Q1 2018 and 9 closed out, a net change of +7 holders.
- The largest Wave Life Sciences buyer in Q1 2018 was Boxer Capital, an estimated $33.6M added.
- The largest Wave Life Sciences seller in Q1 2018 was Great Point Partners, an estimated $11.6M sold.
Based on aggregated 13F filings for Q1 2018.